Structure via PubChem · Public domain (PubChem)
xylopropamine
Sign in to saveXylopropamine, also known as 3,4-dimethylamphetamine (DMeA) and sold under the brand names Perhedrin and Esanin, is a stimulant drug of the phenethylamine and amphetamine families which was developed and marketed as an appetite suppressant in the 1950s.
In the Vinony graph
Within Vinony's link graph, xylopropamine is referenced by 1,518 other articles, and connects out to amphetamines, N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine and phenethylamine.
Vinony files it under Anorectics, Chemical articles with multiple CAS registry numbers and Chemical pages without DrugBank identifier.
Its subject is documented across 8 Wikipedia language editions.
Chemical data
- Formula
- C11H17N
- Molecular weight
- 163.26 g/mol
- IUPAC name
- 1-(3,4-dimethylphenyl)propan-2-amine
- SMILES
- CC1=C(C=C(C=C1)CC(C)N)C
- InChIKey
- ZSZUWPRERIPUBM-UHFFFAOYSA-N
- XLogP
- 2.4
- Polar surface area
- 26 Ų
- H-bond donors
- 1
- H-bond acceptors
- 1
- Formal charge
- 0
via PubChem
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 163.136
Show 2 more facts
- chemical formula
- C₁₁H₁₇N
- canonical SMILES
- CC1=C(C=C(C=C1)CC(C)N)C
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
3 sectionsContents
- See also
- References
- External links
Xylopropamine, also known as 3,4-dimethylamphetamine (DMeA) and sold under the brand names Perhedrin and Esanin, is a stimulant drug of the phenethylamine and amphetamine families which was developed and marketed as an appetite suppressant in the 1950s.
Xylopropamine was briefly sold as the sulfate salt, but it was not widely marketed. Other related amphetamine derivatives such as 2,4-dimethylamphetamine were also investigated for the same purpose, however these drugs had negative side effects such as high blood pressure and were not very successful, mainly due to the introduction of alternative drugs like phentermine which had similar efficacy but fewer side effects.
Excerpted from Wikipedia’s “xylopropamine” article, available under the CC BY-SA 4.0 licence.